University of California San Francisco
Give to UCSFA long-held vision came into view Monday as UCSF neuroscientists and clinical researchers shared their ambitious plans to attack debilitating neurological diseases through innovative collaborations.
UCSF researchers have created the first transgenic mouse to display the earliest signs of Parkinson’s disease using the genetic mutation that is known to accompany human forms of the disease.
A prominent neuroscientist, a global humanitarian relief organizer, a pioneering pediatrician and two supporters of basic biomedical research will receive the UCSF Medal at the 2010 Founders Day banquet tonight.
In a study of alcoholics who entered treatment for drinking, those who stayed sober for at least one year had the same levels of key biochemical indicators of brain health as non-alcoholic controls at the time they entered treatment. In contrast, the study showed, those who relapsed during that year had significantly lower levels of those indicators.
Scientists are reporting what they say is compelling evidence that some powerful non-heritable, environmental factor likely plays a key role in the development of multiple sclerosis.
UCSF’s Louann Brizendine, author of “The Male Brain” and “The Female Brain” will talk at UCSF on April 29.
The public is invited to a free forum on new research and emerging treatments in mental health at UCSF’s Langley Porter Psychiatric Institute on April 24.
The UCSF School of Medicine is ranked among the top five medical schools in the nation in a new survey on “America’s Best Graduate Schools” conducted by <i>U.S. News & World Report</i>.
New research investigating neurological decline in a population of “super healthy” elderly subjects found that the decline in neurological function of the peripheral nervous system attributed to aging may be related to metabolic factors, such as blood sugar levels, even if these factors are within the normal range.
A UCSF-led study examining the impact of statins on the progression of multiple sclerosis found a lower incidence of new brain lesions in patients taking the cholesterol-lowering drug in the early stages of the disease as compared to a placebo.
A new report by the Institute of Medicine has found that military service in the Persian Gulf War is a cause of post-traumatic stress disorder in some veterans.